anti-CD3/anti-EpCAM bispecific T-cell engager TYC-201 nanorings (Tychon Bioscience)

N/A

Report date: 2025/01/26 18:34:25

Base Information

Drug Nameanti-CD3/anti-EpCAM bispecific T-cell engager TYC-201 nanorings (Tychon Bioscience)
Drug Alias Nameanti-CD3/anti-EpCAM bispecific PAR T-cell therapy TYC-201 nanorings (Tychon Bioscience)anti-CD3/anti-EpCAM bispecific prosthetic antigen receptor T-cell therapy chemically self-assembled nanorings (Tychon Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionEpithelial cell adhesion molecule modulatorsT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3Epithelial cell adhesion molecule
Therapy Area/IndicationsSolid tumoursColonic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTychon Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesTychon Bioscience Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColonic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A